| Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 M Rolland, PT Edlefsen, BB Larsen, S Tovanabutra, E Sanders-Buell, ... Nature 490 (7420), 417-420, 2012 | 489 | 2012 |
| Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines AW Chung, M Ghebremichael, H Robinson, E Brown, I Choi, S Lane, ... Science translational medicine 6 (228), 228ra38-228ra38, 2014 | 434 | 2014 |
| SARS-CoV-2 variants in patients with immunosuppression L Corey, C Beyrer, MS Cohen, NL Michael, T Bedford, M Rolland New England Journal of Medicine 385 (6), 562-566, 2021 | 426 | 2021 |
| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 358 | 2019 |
| Prospective study of acute HIV-1 infection in adults in East Africa and Thailand ML Robb, LA Eller, H Kibuuka, K Rono, L Maganga, S Nitayaphan, ... New England Journal of Medicine 374 (22), 2120-2130, 2016 | 324 | 2016 |
| Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection DJ Colby, L Trautmann, S Pinyakorn, L Leyre, A Pagliuzza, E Kroon, ... Nature medicine 24 (7), 923-926, 2018 | 322 | 2018 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial M Rolland, S Tovanabutra, AC Decamp, N Frahm, PB Gilbert, ... Nature medicine 17 (3), 366-371, 2011 | 258 | 2011 |
| A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants B Dearlove, E Lewitus, H Bai, Y Li, DB Reeves, MG Joyce, PT Scott, ... Proceedings of the National Academy of Sciences 117 (38), 23652-23662, 2020 | 244 | 2020 |
| HIV-1 group M conserved elements vaccine M Rolland, DC Nickle, JI Mullins PLoS pathogens 3 (11), e157, 2007 | 219 | 2007 |
| Definition of the viral targets of protective HIV-1-specific T cell responses B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ... Journal of translational medicine 9, 1-20, 2011 | 188 | 2011 |
| Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads M Rolland, D Heckerman, W Deng, CM Rousseau, H Coovadia, K Bishop, ... PloS one 3 (1), e1424, 2008 | 183 | 2008 |
| Central role of reverting mutations in HLA associations with human immunodeficiency virus set point PC Matthews, A Prendergast, A Leslie, H Crawford, R Payne, ... Journal of virology 82 (17), 8548-8559, 2008 | 177 | 2008 |
| HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load CM Rousseau, MG Daniels, JM Carlson, C Kadie, H Crawford, ... Journal of virology 82 (13), 6434-6446, 2008 | 168 | 2008 |
| CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control B Mothe, A Llano, J Ibarrondo, J Zamarreno, M Schiaulini, C Miranda, ... PloS one 7 (1), e29717, 2012 | 158 | 2012 |
| SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity MG Joyce, WH Chen, RS Sankhala, A Hajduczki, PV Thomas, M Choe, ... Cell reports 37 (12), 2021 | 138 | 2021 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 137 | 2022 |
| Viral evolution and escape during acute HIV-1 infection CL Boutwell, MM Rolland, JT Herbeck, JI Mullins, TM Allen The Journal of infectious diseases 202 (Suppl 2), S309, 2010 | 137 | 2010 |
| Coping with viral diversity in HIV vaccine design DC Nickle, M Rolland, MA Jensen, SLK Pond, W Deng, M Seligman, ... PLoS computational biology 3 (4), e75, 2007 | 122 | 2007 |
| Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes JT Herbeck, M Rolland, Y Liu, S McLaughlin, J McNevin, H Zhao, K Wong, ... Journal of virology 85 (15), 7523-7534, 2011 | 108 | 2011 |
